摘要
目的探讨住院患者医院感染常见病原菌的分布特点及其耐药特征,为指导临床合理应用抗菌药物提供参考依据。方法收集2013年至2014年医院各临床科室住院患者送检的标本进行检查,采用法国生物梅里埃公司的VITEK-2 Compact全自动细菌鉴定仪进行菌株鉴定及药物敏感性试验,并采用WHONET 5.5进行数据统计分析。结果共分离出9 149株感染病原菌,其中革兰阴性菌共6 647株,占72.65%,以大肠埃希菌、肺炎克雷伯菌、铜绿假单胞菌、鲍曼不动杆菌为主;革兰阳性菌共2 502株,占27.35%,以金黄色葡萄球菌、肺炎链球菌、粪肠球菌、溶血葡萄球菌为主。大肠埃希菌和肺炎克雷伯菌对头孢唑林、头孢曲松和甲氧苄啶磺胺甲唑的耐药率均超过50%;流感嗜血菌对氨苄西林、左氧氟沙星和甲氧苄啶磺胺甲唑的耐药率分别为61.45%、60.24%和74.70%;阴沟肠杆菌对头孢曲松和氨曲南的耐药率分别为58.90%和50.92%。主要革兰阴性菌对阿米卡星、亚胺培南、美罗培南、头孢替坦、头孢西丁和头孢哌酮钠舒巴坦钠的耐药率较低,均低于20%;而主要非发酵菌中以鲍曼不动杆菌对常见抗菌药物的耐药率较高。主要革兰阳性菌除对万古霉素和利奈唑胺耐药率为0外,对其他常见抗菌药物均有不同程度的耐药率,其中对青霉素的耐药率均超过45%,对红霉素的耐药率均超过65%。屎肠球菌和粪肠球菌对万古霉素的耐药率分别为2.78%和1.15%,对利奈唑胺耐药率分别为2.78%和11.06%,对其他抗菌药物耐药率较高。结论医院常见病原菌以革兰阴性菌为主,对常见的抗菌药物的耐药率偏高,必须加强病原菌分布及耐药性检测,指导临床合理运用抗菌药物。
Objective To investigate the distribution and drug resistance of common pathogens, to provide guidance for reasonable clinical use of antibiotics and control nosocomial infections. M ethods Specimens were collected and indentified from 2013 to 2014 in hospitalized patients with various clinical departments. The bacterial identification was indentified and performed by VITEK- 2 Compact of Biomeriex, France, then the drug susceptibility testing was performed, and the data were analyzed by WHONET 5. 5 software. Results A total of 9 149 strains of pathogens were isolated from 2013- 2014, among which the gram- negative bacteria were 6 647 strains, accounting for 72. 65%, of which, and the top 4 pathogens in order were escherichia coli, klebsiella pneumonia, pseudomonas aeruginosa and acinetobacter baumannii; gram- positive bacterium were 2 502 strains, accounting for 27. 35%, and the top 4 pathogens in order were staphylococcus aureus, streptococcus pneumoniae, enterococcus faecalis, staphylococcus haemolyticus. The drug resistance rate of escherichia coli and klebsiella pneumonia to cefazolin, ceftriaxone and trimethoprim / sulfamethoxazole were more than 50%; the drug resistance rate of hemophilus influenzae to ampicillin, levofloxacin and rimethoprim / sulfamethoxazole were 61. 45%, 60. 24% and74. 70%, respectively; the drug resistance rate of enterobacter cloacae to ceftriaxone and aztreonam were 58. 90% and 50. 92%. The main gram- negative bacilli were especially sensitive to amikacin, imipenem, meropenem, cefotetan, cefoxitin, cefoperazone / sulbactam, and the drug resistance rate were more less 20%; the drug resistance rate of the main non- fermentataive bacterial to acinetobacter baumannii to common antibacterial drugs were high. The drug resistance rate of the main gram- positive bacteria in addition to vancomycin and linzolid were 0, and had different degrees of drug resistance rate to common antibacterial drugs, among which to penicillin was more than 45%, and to erythrocin were more than 65%. The drug resistance rate of enterococcus faecium and enterococcus faecalis to vancomycin were 2. 78% and 1. 15%, and to linezolid were 2. 78% and 11. 06%, but the drug resistance rate of enterococcus faecium and enterococcus faecalis to common antibacterial drugs were high. Conclusion Pathogenic bacteria are the main gram- negative bacilli in clinic, and they have drug resistance rate to common antibacterial, thus drug resistance monitoring should be strengthened in order to instruct rational use of antibiotics.
出处
《中国药业》
CAS
2016年第9期48-52,共5页
China Pharmaceuticals
关键词
医院感染
病原菌
抗菌药物
耐药性
合理用药
hospital infections
pathogen
antibiotics
drug resistance
rational drug use